about
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metaboli...
Read More
192.01
2.11
(1.11%)
1.8M
XNYS Volume
XNYS 16 Mar, 2026 5:30 PM (EDT)
Low Financial Strength
Expensive Valuation
No Score Avaliable
Astrazeneca plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..